The Illinois Department of Public Health has begun distributing a new COVID-19 treatment designed for use in adults with mild-to-moderate cases that are at-risk of severe illness.
The new treatment, known as bebtelovimab, is a monoclonal antibody that received an emergency use authorization from the Food and Drug Administration earlier this month.
“This newest COVID-19 treatment authorized by the FDA will continue to move us forward as we co-exist with COVID-19,” IDPH Director Dr. Ngozi Ezike said. “While vaccination and boosting are still the best protection against severe illness, this new treatment can help keep people out of the hospital.”
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: